Precision Medicine & Functional Genomics 2024 (PMFG 2024)

Theme: Precision Medicine and the Future of Genomics
Dates: 3–5 December 2024
Pre-Summit Masterclasses: 1–2 December 2024
Venue: Qatar National Convention Centre (QNCC), Doha, Qatar
Format: In-person with scientific masterclasses
CME/CPD: Accredited Group Learning Activity

Overview

Precision Medicine & Functional Genomics 2024 (PMFG 2024) marked a significant milestone in Sidra Medicine’s flagship conference series, celebrating a decade of advancing genomics and precision medicine in the region. Since its inception, PMFG has grown into a leading international forum that brings together clinicians, researchers, policymakers, and industry leaders to explore the translation of genomic science into clinical impact.

The 2024 Summit focused on integrating genomic knowledge into healthcare systems, advancing diagnostics and therapeutics, and strengthening global collaboration in precision medicine. Through multidisciplinary dialogue and scientific exchange, PMFG 2024 reinforced Sidra Medicine’s leadership in population health genomics, rare disease research, and innovative therapeutic development.

Conference Themes

PMFG 2024 was organized around three central pillars reflecting the evolution of precision medicine:

• Genomics for All – Advancing newborn and population genomic screening programs and expanding equitable access to genomic medicine.
• Precision Diagnostics – Enhancing diagnostic accuracy through multi-omics technologies, rare disease gene discovery, and genomic data integration.
• Next-Generation Therapeutics – Accelerating innovation in gene therapy, genome editing, and personalized treatment strategies.

Cross-cutting themes included artificial intelligence in healthcare, implementation science, global genomic diversity, and ethical frameworks guiding responsible innovation.

Program Highlights

PMFG 2024 featured plenary lectures, thematic scientific tracks, expert panels, and interactive discussions led by internationally recognized leaders in genomics and translational medicine.

Plenary Sessions

Global pioneers in genomic medicine presented advancements in population genomics, therapeutic innovation, and clinical implementation strategies, highlighting real-world applications and emerging research directions.

Scientific Tracks

Focused sessions explored:

• Genomic newborn screening initiatives
• Large-scale population cohort studies
• Rare disease diagnostics and gene discovery
• Precision oncology and targeted therapies
• Genome editing technologies and gene therapy platforms
• AI-driven clinical decision support systems
• Ethical, regulatory, and policy considerations in genomic healthcare

Pre-Summit Masterclasses

Hands-on masterclasses provided advanced training in:

• Rare disease genomic analysis and interpretation
• Standards and frameworks for genomic data sharing
• Artificial intelligence applications in health innovation
• Foundations of genetic counseling and clinical genomics

These sessions supported capacity building and knowledge transfer across the regional precision medicine ecosystem.

Distinguished Speakers

PMFG 2024 welcomed internationally renowned experts in genomics, computational biology, translational research, and precision therapeutics from leading institutions worldwide. Speakers shared insights from national genome programs, rare disease initiatives, and therapeutic development pipelines.

Sidra Medicine faculty and national partners showcased research advances emerging from Qatar’s expanding precision medicine landscape, highlighting collaborative efforts in genomic screening, data integration, and translational discovery.

Learning Objectives & Accreditation

At the conclusion of PMFG 2024, participants were able to:

• Assess advances in population and newborn genomic screening programs.
• Discuss strategies for implementing precision diagnostics within healthcare systems.
• Evaluate emerging gene therapy and genome editing approaches.
• Explore applications of artificial intelligence in genomic medicine.
• Examine ethical and regulatory considerations in large-scale genomic initiatives.

The conference was accredited as a Group Learning Activity and provided continuing medical education credits in accordance with national accreditation standards.

Scientific Impact

PMFG 2024 strengthened global partnerships and reinforced Qatar’s role as a regional leader in precision medicine. By fostering collaboration across academia, healthcare, and industry, the Summit accelerated dialogue on translating genomic discoveries into measurable clinical outcomes.

Through scientific exchange, capacity building, and international engagement, PMFG 2024 continued to advance Sidra Medicine’s mission to integrate precision medicine into routine clinical care and improve health outcomes locally and globally.